EntryPoint Capital’s Smith & Wesson SWBI Stock Holding History

EntryPoint Capital’s Portfolio SWBI Stock Details SWBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-19,885	Closed	-$195K	–	852
2025 Q3	$195K	Sell	19,885 -3,718	-16%	-$31.7K	0.08%	558
2025 Q2	$205K	Sell	23,603 -1,829	-7%	-$17.3K	0.1%	477
2025 Q1	$237K	Buy	+25,432	New	+$262K	0.11%	454

Other funds holding SWBI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

EntryPoint Capital's SWBI Position: Q4 2025 in Review

EntryPoint Capital sold out of Smith & Wesson (SWBI) in Q4 2025, closing a stake of 19,885 shares — an estimated $195K sold.

EntryPoint Capital first reported a position in SWBI in Q1 2025 and held it in 3 quarters. The position peaked at $237K in Q1 2025. 169 funds tracked by Wall St. Rank hold SWBI as of Q4 2025.

EntryPoint Capital reported no remaining Smith & Wesson position as of Q4 2025 after selling out during the quarter.
EntryPoint Capital sold 19,885 Smith & Wesson shares in Q4 2025, an estimated $195K.
EntryPoint Capital first reported a position in Smith & Wesson in Q1 2025 and held it in 3 quarters.
EntryPoint Capital's Smith & Wesson position peaked at $237K in Q1 2025.
169 funds tracked by Wall St. Rank held Smith & Wesson as of Q4 2025.

Based on EntryPoint Capital's 13F filing for Q4 2025, filed 12 Feb 2026.